2-Methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo(1,2-a)pyrazin-3-one hydrochloride

CAS: 128322-44-1

Rif. 3D-EM58693

Informazioni sul prodotto

• Nome: 2-Methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo(1,2-a)pyrazin-3-one hydrochloride
• Sinonimi: MCLA, Mcla, Hydrochloride, Cypridina Luciferin Methoxy-Analogue, 2-Methyl-6-(4-Methoxyphenyl)-3,7-Dihydroimidazo[1,2-A]Pyrazin-3(7H)-One Hydrochloride, 2-Methyl-6-(4-Methoxyphenyl)-3,7-Dihydroimidazo[1,2-A]Pyrazin-3-One Hydrochloride, 6-(4-Methoxyphenyl)-2-Methyl-3,7-Dihydroimidazo[1,2-A]Pyrazin-3(7H)-One Hydrochloride, 6-(4-Methoxyphenyl)-2-Methyl-3,7-Dihydroimidazo[1,2-A]Pyrazin-3-One Hydrochloride, 6-(4-Meophe.)-2-Me-3,7-Dihydroimidazo(A)Pyrazin-3(7H)-On-Hcl, 6-(4-methoxyphenyl)-2-methylimidazo[1,2-a]pyrazin-3(7H)-one hydrochloride
• CAS: 128322-44-1

Descrizione

2-Methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo(1,2-a)pyrazin-3-one hydrochloride (ABI) is a potent and selective inhibitor of the enzyme toll-like receptor. The drug has been shown to decrease the metabolic rate in experimental models. ABI has also been used as an analog for other compounds to study their effects on redox potentials and reactive species. It is unclear how ABI inhibits protein synthesis by polymerase chain reaction (PCR). One possible mechanism is that it may inhibit the binding of primers to DNA. ABI also inhibits the production of chemokines which are small proteins that stimulate inflammatory responses. This drug can be used in autoimmune diseases such as rheumatoid arthritis and multiple sclerosis.

• Marchio: Biosynth

Proprietà chimiche

• Peso molecolare: 290.72 g/mol
• Purezza: Min. 95%